Pharmafile Logo

thinkemotive

- PMLiVE

Daily Brief: ASCO latest, Europe cautions on immunotherapy, rejects Duchenne treatment

All the latest from the frontline of pharma, biotech and healthcare

- PMLiVE

ASCO data back up Merck & Co’s dominance in lung cancer

Keytruda improved survival of previously-untreated NSCLC patients by four-eight months, according to data

Bristol-Myers Squibb (BMS) building

BMS presses go on Nektar combo pivotal trials, despite data debate

The data isn’t mature enough to give an accurate ORR reading, says companies

- PMLiVE

Changes to look out for in Medical Devices Regulations

Will digital lead to a greater compliance burden?

- PMLiVE

Brave real world? How healthcare communication needs to adapt

The evaluation of drugs and medical devices has moved into a new era. Randomised clinical trials (RCTs) remain the gold standard for evaluating efficacy and safety, however, their limitations are...

- PMLiVE

Protecting patient privacy

The most effective approaches  to compliance

- PMLiVE

Digging deeper to connect with the powerful force of patient understanding

EphMRA's president Karsten Trautmann advocates a holistic approach to market research

Getting multichannel marketing right

How the atomisation of communication is challenging and benefiting pharma

- PMLiVE

Tracking comms trends: beyond the event

There’s no substitute for face-to-face meetings. But meetings require a significant investment, with often substantial venue and travel costs, as well as the opportunity costs of the audience and organiser’s...

- PMLiVE

The Difference Collective boosts its creative and media offerings

Stuart Mayell and Jo Willey join the group

- PMLiVE

Kevin Sin joins GSK

He becomes senior VP, head of worldwide business development

- PMLiVE

NICE backs Tesaro’s Zejula via the CDF

Recommends the drug for second-line use in ovarian cancer patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links